Civica Inc. announced the selection of Ypsomed AG as the manufacturer and supplier of insulin dosing injector pens for Civica's affordable insulins. As previously announced, Civica plans to produce three insulin biosimilars glargine, lispro and aspart each of which will be available both in vials and prefilled pens, and sell the insulins at significantly lower prices than insulins currently on the market. To ensure redundancy of supply, Ypsomed will provide injector dosing pens from their two manufacturing facilities in Switzerland and Germany.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
372 CHF | -3.00% | -0.93% | +22.77% |
Apr. 16 | Ypsomed Partners with ten23 health for Wearable Injector Product Commercialization | MT |
Apr. 12 | Dental Equipment Company Straumann Names New Chair | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.77% | 5.73B | |
-4.01% | 105B | |
-4.77% | 66.74B | |
+7.87% | 52.63B | |
+16.18% | 47.48B | |
0.00% | 39.68B | |
+7.17% | 27.78B | |
-1.23% | 26.27B | |
+3.80% | 26.11B | |
+12.35% | 25.38B |
- Stock Market
- Equities
- YPSN Stock
- News Ypsomed Holding AG
- Civica Welcomes Ypsomed as Injection Pen Partner for Its Affordable Insulin Initiative